Bristol Myers Squibb to Present at J.P. Morgan’s 39th Annual Virtual Healthcare Conference
Bristol Myers Squibb (NYSE: BMY) announced its participation in the J.P. Morgan 39th Annual Virtual Healthcare Conference, scheduled for January 11, 2021, at 7:30 a.m. EST. CEO Giovanni Caforio will present and respond to questions. Investors and the public can listen to the live webcast at investor.bms.com. Materials related to the presentation will be available on the website at the start of the event, with an archived version accessible later that day.
- None.
- None.
Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at J.P. Morgan’s 39th Annual Virtual Healthcare Conference, which will be webcast on Monday, January 11, 2021. Giovanni Caforio, M.D., Board Chair and Chief Executive Officer will make a formal presentation and answer questions about the company at 7:30 a.m. EST.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Material related to the company’s presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
Corporatefinancial_news
View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005007/en/
FAQ
When is Bristol Myers Squibb presenting at the J.P. Morgan Healthcare Conference?
Who will represent Bristol Myers Squibb at the conference?
How can I listen to the Bristol Myers Squibb presentation?
Will there be a recording of the Bristol Myers Squibb presentation?
What is the stock symbol for Bristol Myers Squibb?
